H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro

Min Luo; Yao Xiong; Yan Lin; Rong Liang; Yongqiang Li; Lianying Ge

doi:10.12659/MSM.930215

15 May 2021 : Database Analysis

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro

Min Luo^1ABCE, Yao Xiong^2BCE, Yan Lin^1CD, Rong Liang^1CD, Yongqiang Li^1D, Lianying Ge^3ADE*

DOI: 10.12659/MSM.930215

Med Sci Monit 2021; 27:e930215

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Bioinformatic analysis of HHLA2 expression in hepatocellular carcinoma. (A) Heat map of genes differentially expressed between cancer and normal tissue from the data set GSE33006. (B) Gene ontology analysis of genes from panel A.

Back to the Article

H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro

Your Privacy